CCN3 and myeloid sarcoma: To understand the relationship between relative CCN3+ immunoreactivity and MS pathology, we calculated the percent area of specific anti-CCN3+ signal for normal-appearing, demyelinated, and remyelinated white and grey matter, respectively, from brain tissue blocks from 17 cases.